StockWatch
·

ORAMED PHARMACEUTICALS INC.

Ticker: 1176309

P/L Snapshot

Q1 FY25 · consolidated

vs Q2 FY23
Revenue
2.00
+198.5%
Expenditure
6.50
+45.4%
Net Profit
-7.64
-542.0%
OPM %
-100.00%

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-13.85-6.670.517.6914.87Q4 FY21Q1 FY22Q2 FY22Q3 FY22Q3 FY22Q1 FY23Q1 FY23Q2 FY23Q2 FY23Q1 FY25
Price Chart
Latest News